Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"I am genuinely very excited about the reduction in stage four cancers."
— Prof Charles Swanton , Academic
"Without mortality data and a transparent account of harms, claims of population benefit from multi-cancer early detection remain speculative."
— Prof Richard Houlston , Academic
Key People
Locations
All Coverage
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Similar Stories
Related coverage based on topic and tags
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
August 19, 2026 at 07:00 PMUS drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.
August 26, 2026 at 10:02 PMHome-testing kits now available for women in England who have missed cervical screening
Nearly 4 million women in England can order a self-testing kits to check for high-risk HPV.
August 24, 2026 at 11:27 PMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMBioNTech halts mRNA colorectal cancer vaccine trial after safety review - Reuters
BioNTech halts mRNA colorectal cancer vaccine trial after safety review Reuters
August 28, 2026 at 05:12 PMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AM